- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
J. Safra Sarasin Holding AG Cuts Boston Scientific Corporation $BSX Stock Holdings
The institutional investor reduced its stake in the medical equipment provider during the fourth quarter.
Mar. 31, 2026 at 9:53am
Got story updates? Submit your updates here. ›
J. Safra Sarasin Holding AG, an institutional investor, decreased its position in Boston Scientific Corporation (NYSE:BSX) by 11.8% during the fourth quarter, according to a recent 13F filing with the SEC. The firm now owns 270,465 shares of the medical equipment provider's stock, valued at $25,789,000.
Why it matters
This reduction in holdings by a major institutional investor could signal a shift in sentiment around Boston Scientific's stock. Institutional investors like J. Safra Sarasin often have significant influence on the overall market performance of a company's shares.
The details
According to the 13F filing, J. Safra Sarasin sold 36,293 shares of Boston Scientific stock during the fourth quarter. The firm now holds a total of 270,465 shares in the medical equipment provider.
- The reduction in holdings occurred during the fourth quarter of the year.
The players
J. Safra Sarasin Holding AG
An institutional investor that reduced its position in Boston Scientific Corporation.
Boston Scientific Corporation
A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.
The takeaway
The reduction in holdings by J. Safra Sarasin Holding AG could signal a broader shift in sentiment around Boston Scientific's stock. Investors will be closely watching to see if other major institutional investors follow suit or if Boston Scientific can regain their confidence.
